We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

18 hedge funds and large institutions have $6.22M invested in Bio-Path Holdings Inc in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,889% more capital invested

Capital invested by funds: $208K → $6.22M (+$6.01M)

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

6% more funds holding

Funds holding: 17 → 18 (+1)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
4
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.28M
2
BlackRock
BlackRock
New York
+$363K
3
Two Sigma Investments
Two Sigma Investments
New York
+$227K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$180K
5
VF
Virtu Financial
New York
+$151K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$9K
2
RCA
Rowland Carmichael Advisors
Arizona
-$8K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$7K
4
Northern Trust
Northern Trust
Illinois
-$3K
5
TSS
Two Sigma Securities
New York
-$3K

BPTH Hedge Fund Activity: Q1 2019 in Review

18 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2019, worth a combined $6.22M — up 2,889% from $208K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BPTH positions and 7 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.28M. The largest seller was Geode Capital Management, exiting entirely with an estimated $9K sold.

  • 18 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2019, up from 17 in Q4 2018.
  • Funds reported $6.22M of Bio-Path Holdings Inc stock for Q1 2019, up 2,889% quarter-over-quarter.
  • 8 funds opened new Bio-Path Holdings Inc positions in Q1 2019 and 7 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q1 2019 was Renaissance Technologies, an estimated $1.28M added.
  • The largest Bio-Path Holdings Inc seller in Q1 2019 was Geode Capital Management, an estimated $9K sold.

Based on aggregated 13F filings for Q1 2019.